Glucagon-like peptide 1 receptor agonists: inpatient use during the COVID-19 pandemic
A. Pineau Mitchell, M.B. Whyte, O. Mustafa
King’s College Hospital, London, UK
A. Pineau Mitchell, M.B. Whyte, O. Mustafa
King’s College Hospital, London, UK
Miller KH; Huntriss R; Jones L
Oviva UK Limited, London, UK
Miller KH; Huntriss R; Noble Jesus C; Jones L 1.
Oviva UK Limited, London, UK
V Milbourn, Dr S Bade, Dr R Yamin, L Boddington, Dr D Fowler, Dr C Parkinson, Dr S Sharma
Diabetes Foot Clinic, Ipswich Hospital (ESNEFT), Ipswich, Suffolk, United Kingdom
ME Lewis, G Carrieri, CE Foster, SL Baker, RC Andrews, IF Douek
Department of Endocrinology and Diabetes, Musgrove Park Hospital, Taunton, UK
Larsen N, Khine C, Khan SMS
Sherwood Forest Hospital NHS Foundation Trust
Joshi Kshama; Vartak Manjiri; Antonio Peña-Fernández; Parvez I. Haris
School of Allied Health Sciences, De Montfort University, Leicester, UK
Joshi Kshama; Vartak Manjiri; Antonio Peña-Fernández; Parvez I. Haris
School of Allied Health Sciences, De Montfort University, Leicester, UK
Krishnasamy Ganapathy K D1; Palani Raghavendar1; Coulden Amy1,2; Hanif Wasim1,2; Ghosh Sandip3
1 Department of Diabetes, University Hospitals Birmingham Trust, Birmingham, UK
2 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham,UK
3 Diabetes Translational Research group, University Hospitals Birmingham,NHSFT
Rhodri King1; John P.H. Wilding2; Rachel L. Batterham3; Salvatore Calanna4; Luc F. Van Gaal5; Barbara M. McGowan6; Julio Rosenstock7; Marie T.D. Tran4; Sean Wharton8; Koutaro Yokote9; Niels Zeuthen4; Robert F. Kushner10